Literature DB >> 24777978

Importance of estrogen metabolites.

Sarah H Lindsey1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24777978      PMCID： PMC4057300          DOI： 10.1161/HYPERTENSIONAHA.114.03382

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

Review 1.  The saga of the ring B unsaturated equine estrogens.

Authors:  B R Bhavnani
Journal:  Endocr Rev       Date:  1988-11       Impact factor: 19.871

2.  Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice.

Authors:  Jun Ho Kim; Matthew S Meyers; Saja S Khuder; Simon L Abdallah; Harrison T Muturi; Lucia Russo; Chandra R Tate; Andrea L Hevener; Sonia M Najjar; Corinne Leloup; Franck Mauvais-Jarvis
Journal:  Mol Metab       Date:  2014-01-09       Impact factor: 7.422

3.  Cooxidation of steroidal and non-steroidal estrogens by purified prostaglandin synthase results in a stimulation of prostaglandin formation.

Authors:  G H Degen; J A McLachlan; T E Eling; K Sivarajah
Journal:  J Steroid Biochem       Date:  1987-06       Impact factor: 4.292

4.  27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen.

Authors:  Michihisa Umetani; Hideharu Domoto; Andrew K Gormley; Ivan S Yuhanna; Carolyn L Cummins; Norman B Javitt; Kenneth S Korach; Philip W Shaul; David J Mangelsdorf
Journal:  Nat Med       Date:  2007-09-16       Impact factor: 53.440

5.  Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women.

Authors:  A Heather Eliassen; Regina G Ziegler; Bernard Rosner; Timothy D Veenstra; John M Roman; Xia Xu; Susan E Hankinson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

Review 6.  Potential vascular actions of 2-methoxyestradiol.

Authors:  Raghvendra K Dubey; Edwin K Jackson
Journal:  Trends Endocrinol Metab       Date:  2009-09-04       Impact factor: 12.015

7.  2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor.

Authors:  Sivaramakrishna Koganti; Russell Snyder; Upendra Gumaste; Vardan T Karamyan; Thomas Thekkumkara
Journal:  Eur J Pharmacol       Date:  2013-11-18       Impact factor: 4.432

8.  Sex differences in primary hypertension.

Authors:  Kathryn Sandberg; Hong Ji
Journal:  Biol Sex Differ       Date:  2012-03-14       Impact factor: 5.027

9.  Urine biomarkers of risk in the molecular etiology of breast cancer.

Authors:  Nilesh W Gaikwad; Li Yang; Sandhya Pruthi; James N Ingle; Nicole Sandhu; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Breast Cancer (Auckl)       Date:  2009-01-06

10.  Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension.

Authors:  Kevin White; Anne Katrine Johansen; Margaret Nilsen; Loredana Ciuclan; Emma Wallace; Leigh Paton; Annabel Campbell; Ian Morecroft; Lynn Loughlin; John D McClure; Matthew Thomas; Kirsty M Mair; Margaret R MacLean
Journal:  Circulation       Date:  2012-08-02       Impact factor: 29.690
  10 in total
  2 in total

1.  Disruption of the cytochrome P-450 1B1 gene exacerbates renal dysfunction and damage associated with angiotensin II-induced hypertension in female mice.

Authors:  Brett L Jennings; Joseph A Moore; Ajeeth K Pingili; Anne M Estes; Xiao R Fang; Alie Kanu; Frank J Gonzalez; Kafait U Malik
Journal:  Am J Physiol Renal Physiol       Date:  2015-02-18

2.  Identification of naturally occurring inhibitors in Xian-Ling-Gu-Bao capsule against the glucuronidation of estrogens.

Authors:  Liangliang He; Chunxia Xu; Ziying Wang; Shuyi Duan; Jinjin Xu; Chuan Li; Xinsheng Yao; Frank J Gonzalez; Zifei Qin; Zhihong Yao
Journal:  Front Pharmacol       Date:  2022-08-04       Impact factor: 5.988
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.